Evidence map›Paper›PMID 32351006›Full record

ArticleJournal of applied clinical medical physics2020

Survey results of 3D-CRT and IMRT quality assurance practice.

Hunter Mehrens, Paige Taylor, David S Followill, Stephen F Kry

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Characterizing the interplay of treatment parameters and complexity and their impact on performance on an IROC IMRT phantom using machine learning.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2023
    Article
  9. Article
  10. Comparing log file to measurement-based patient-specific quality assurance.Physical and engineering sciences in medicine · 2023
    Article
  11. Article
  12. The Value of On-Site Proton Audits.International journal of radiation oncology, biology, physics · 2022
    Article
  13. Article
  14. Survey of patient-specific quality assurance practice for IMRT and VMAT.Journal of applied clinical medical physics · 2021
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hunter MehrensImaging and Radiation Core Houston QA Center, Houston, TX, USA.
Paige TaylorImaging and Radiation Core Houston QA Center, Houston, TX, USA.
David S FollowillImaging and Radiation Core Houston QA Center, Houston, TX, USA.
Stephen F KryImaging and Radiation Core Houston QA Center, Houston, TX, USA.

Funding

IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
Correcting Dose Calculation Errors in Radiation OncologyR01CA214526 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KRY, STEPHEN F · 2017 to 2020
$594k
Department of HealthNCI NIH HHS R01 CA214526NCI NIH HHS U24 CA180803
6 · The paper itself

Abstract

purposeTo create a snapshot of common practices for 3D-CRT and intensity-modulated radiation therapy (IMRT) QA through a large-scale survey and compare to TG-218 recommendations.

methodsA survey of 3D-CRT and IMRT QA was constructed at and distributed by the IROC-Houston QA center to all institutions monitored by IROC (n = 2,861). The first part of the survey asked about methods to check dose delivery for 3D-CRT. The bulk of the survey focused on IMRT QA, inquiring about treatment modalities, standard tools used to verify planned dose, how assessment of agreement is calculated and the comparison criteria used, and the strategies taken if QA fails.

resultsThe most common tools for dose verification were a 2D diode array (52.8%), point(s) measurement (39.0%), EPID (27.4%), and 2D ion chamber array (23.9%). When IMRT QA failed, the highest average rank strategy utilized was to remeasure with the same setup, which had an average position ranking of 1.1 with 90.4% of facilities employing this strategy. The second highest average ranked strategy was to move to a new calculation point and remeasure (54.9%); this had an average ranking of 2.1.

conclusionThe survey provided a snapshot of the current state of dose verification for IMRT radiotherapy. The results showed variability in approaches and that work is still needed to unify and tighten criteria in the medical physics community, especially in reference to TG-218's recommendations.

Indexed as

Radiotherapy, ConformalRadiotherapy, Intensity-ModulatedHumansQuality Assurance, Health CareRadiotherapy DosageRadiotherapy Planning, Computer-Assisteddose verificationIMRT QApatient specific QAsurveyTG-218

Identifiers

PMID32351006
PMCPMC7386182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.